PACLITAXEL INJECTION 300MG/50ML – Third Party Manufacturing | Medizia Biotech

Medizia Biotech is a trusted Paclitaxel Injection 300mg/50ml Third Party Manufacturer in India, offering high-quality oncology injectable manufacturing services for pharmaceutical companies, hospitals, institutional suppliers, exporters, and distributors. Our manufacturing facilities follow stringent WHO-GMP and ISO quality standards, ensuring every batch is produced with precision, safety, and regulatory compliance.

Paclitaxel Injection 300mg/50ml is a chemotherapy medicine widely used in the treatment of breast cancer, ovarian cancer, non-small cell lung cancer, Kaposi's sarcoma, and other solid tumors. At Medizia Biotech, we provide reliable contract manufacturing, private label manufacturing, and custom branding solutions to help businesses expand their oncology product portfolio with confidence.

Our advanced manufacturing infrastructure supports small batch production, bulk manufacturing, and customized packaging according to client requirements. We maintain strict quality control throughout production, ensuring consistent product quality, timely delivery, and dependable supply for domestic and international markets.

Why Choose Medizia Biotech?

• WHO-GMP & ISO certified manufacturing facility

• Expert Paclitaxel Injection manufacturer in India

• Third party manufacturing for oncology injectables

• Contract manufacturing and private label services

• Small batch and bulk production available

• Export-quality manufacturing standards

• Competitive pricing with timely delivery

• Dedicated support for pharmaceutical businesses

Partner with Medizia Biotech for reliable Paclitaxel Injection 300mg/50ml third party manufacturing, premium-quality oncology injectables, and scalable pharmaceutical manufacturing solutions.